Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02827617. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01460238. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT04771507. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00006226. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00143065. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial
ClinicalTrials.gov study NCT04941716. IPD Sharing: NO. Countries: 1. Publications: 0.
Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00643240. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previ
ClinicalTrials.gov study NCT02640833. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT01732861. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Phase II Clinical Trial of Alemtuzumab to Treat B-cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01982175. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clofarabine in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00028418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in Spain
ClinicalTrials.gov study NCT06125795. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Genetic Study of Chronic Lymphocytic Leukemia Families
ClinicalTrials.gov study NCT00503256. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Study Examining the Effect of Added MabThera Therapy in Patients With Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02080884. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
ClinicalTrials.gov study NCT07218510. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00003829. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00100711. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00019032. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia
ClinicalTrials.gov study NCT00109356. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin's Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT03289182. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.